NASDAQ:VBLT
Delisted

Vascular Biogenics Stock Signals

etoro logo Buy VBLT
*Your capital is at risk
$0.156
+0 (+0%)
At Close: Jan 12, 2024

Latest Data & Signals Issued

Below are some of the latest signals issued for Vascular Biogenics Ltd.

General

Signal Type Signal Value Data
Score 0.000 60 days ( 0 %
Last Price $0.156 0 %
Performance History
7 Days
$0.156 $0.156
0%
30 Days
$0.156 $0.156
0%
12 Mos
$0.144 $0.156
8.33%

6/18

Active Buy Signals

Specific Signals

Short Term
Net score: 15.54
Signal Type Signal Value Importance Data
High / Low N/A Very Low $0.156 - $0.156
Trend - 3 mos -0.81 % High Width: 9.69 %
Pred. range - 3 mos $0.153 - $0.168 Low -1.68 % - 7.85 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Buy Very Low Oct 16, 2023 - 62 days
RSI Short Pivot Signal Buy Very Low Oct 30, 2023 - 52 days
Short MA 3 mos Sell Low Nov 30, -0001 - N/A days
Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days
Short/Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 51.18
Signal Type Signal Value Importance Data
Trend - 12 mos 3.64 % Very High Width: 188.42 %
Pred. range - 12 mos $0.115 - $0.332 High -26.11 % - 113.11 %
Short MA 12 mos Sell Very High Oct 11, 2023 - 65 days
Long MA 12 mos Buy Very High Oct 10, 2023 - 66 days
Short/Long MA 12 mos Sell Very High Sep 01, 2023 - 92 days
Pivot Long Buy Low Oct 16, 2023 - 62 days
RSI Long Pivot Signal Buy Low Nov 08, 2023 - 45 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT VASCULAR BIOGENICS LTD.
Vascular Biogenics
Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antibody-based technology that enables specifically inhibit monocyte migration for immune-inflammatory appli...
GOLDEN STAR
Ticker Change Signal Date
TPR
$140.47
0.306% Jun 04
N
NVRI
$19.53
1.79% May 20
RUN
$12.83
4.91% May 06
GLBE
$31.61
1.71% May 05
SAP
$172.39
5.53% May 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE